Saudi Chemical Holding (TADAWUL:2230) Shareholders Will Want The ROCE Trajectory To Continue
Jan 20
Have your own idea? Try our Stock Screener
Saudi Arabian (Tadawul) Healthcare Sector Analysis
UpdatedJan 20, 2025
DataAggregated Company Financials
Companies27
- 7D-0.5%
- 3M-1.2%
- 1Y-2.5%
- YTD3.0%
The Healthcare is pretty flat in the last 7 days, but Mouwasat Medical Services has stood out, gaining 6.2%. In line with that, the industry has also been flat over the past 12 months. Earnings are forecast to grow by 15% annually.
Sector Valuation and Performance
Has the Saudi Arabian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 20 Jan 2025 | ر.س216.9b | ر.س38.2b | ر.س5.3b | 31.8x | 40.8x | 5.7x |
| Wed, 18 Dec 2024 | ر.س211.4b | ر.س37.0b | ر.س5.3b | 30.3x | 40.2x | 5.7x |
| Fri, 15 Nov 2024 | ر.س201.8b | ر.س36.9b | ر.س5.2b | 29.4x | 38.6x | 5.5x |
| Sun, 13 Oct 2024 | ر.س210.2b | ر.س35.6b | ر.س5.0b | 32.6x | 41.8x | 5.9x |
| Tue, 10 Sep 2024 | ر.س219.5b | ر.س35.5b | ر.س5.0b | 33.3x | 43.8x | 6.2x |
| Thu, 08 Aug 2024 | ر.س210.5b | ر.س34.8b | ر.س4.9b | 31.8x | 43.1x | 6x |
| Sat, 06 Jul 2024 | ر.س217.7b | ر.س34.1b | ر.س4.7b | 36x | 46x | 6.4x |
| Mon, 03 Jun 2024 | ر.س190.5b | ر.س31.7b | ر.س4.4b | 33.2x | 43x | 6x |
| Wed, 01 May 2024 | ر.س211.2b | ر.س30.6b | ر.س4.3b | 36.4x | 49.5x | 6.9x |
| Fri, 29 Mar 2024 | ر.س215.1b | ر.س30.3b | ر.س4.2b | 34.5x | 51.2x | 7.1x |
| Sun, 25 Feb 2024 | ر.س224.5b | ر.س29.5b | ر.س4.0b | 37.1x | 55.6x | 7.6x |
| Tue, 23 Jan 2024 | ر.س199.7b | ر.س29.2b | ر.س3.9b | 35x | 50.7x | 6.8x |
| Thu, 21 Dec 2023 | ر.س187.5b | ر.س29.2b | ر.س3.9b | 32x | 47.6x | 6.4x |
| Sat, 18 Nov 2023 | ر.س182.3b | ر.س29.1b | ر.س4.0b | 33.5x | 45.8x | 6.3x |
| Mon, 16 Oct 2023 | ر.س161.0b | ر.س27.7b | ر.س3.6b | 33.3x | 44.8x | 5.8x |
| Wed, 13 Sep 2023 | ر.س166.7b | ر.س27.5b | ر.س3.6b | 33.4x | 46.6x | 6.1x |
| Fri, 11 Aug 2023 | ر.س181.4b | ر.س26.4b | ر.س3.5b | 38.5x | 52.3x | 6.9x |
| Sun, 09 Jul 2023 | ر.س196.1b | ر.س26.3b | ر.س3.4b | 38.8x | 58.5x | 7.5x |
| Tue, 06 Jun 2023 | ر.س173.7b | ر.س25.2b | ر.س3.1b | 38.1x | 55.3x | 6.9x |
| Thu, 04 May 2023 | ر.س171.7b | ر.س24.3b | ر.س3.0b | 37.4x | 57.4x | 7.1x |
| Sat, 01 Apr 2023 | ر.س167.3b | ر.س23.8b | ر.س3.2b | 34.8x | 52.7x | 7x |
| Mon, 27 Feb 2023 | ر.س138.7b | ر.س23.2b | ر.س2.9b | 37.2x | 47.1x | 6x |
| Wed, 25 Jan 2023 | ر.س135.6b | ر.س23.2b | ر.س2.9b | 36.6x | 46x | 5.8x |
| Fri, 23 Dec 2022 | ر.س129.0b | ر.س23.2b | ر.س2.9b | 33.3x | 43.8x | 5.6x |
| Sun, 20 Nov 2022 | ر.س133.4b | ر.س23.2b | ر.س2.9b | 29.1x | 45.3x | 5.7x |
| Tue, 18 Oct 2022 | ر.س143.8b | ر.س22.8b | ر.س3.0b | 32.9x | 48.7x | 6.3x |
| Thu, 15 Sep 2022 | ر.س126.4b | ر.س22.9b | ر.س3.0b | 30x | 42.6x | 5.5x |
| Sat, 13 Aug 2022 | ر.س135.7b | ر.س22.5b | ر.س3.0b | 42.1x | 45.1x | 6x |
| Mon, 11 Jul 2022 | ر.س121.2b | ر.س22.2b | ر.س2.9b | 39.6x | 41.8x | 5.5x |
| Wed, 08 Jun 2022 | ر.س128.4b | ر.س22.2b | ر.س2.9b | 40.9x | 44.3x | 5.8x |
| Fri, 06 May 2022 | ر.س130.1b | ر.س22.0b | ر.س2.8b | 41.9x | 46.2x | 5.9x |
| Sun, 03 Apr 2022 | ر.س121.7b | ر.س21.7b | ر.س2.7b | 39.4x | 44.7x | 5.6x |
| Tue, 01 Mar 2022 | ر.س108.1b | ر.س20.4b | ر.س2.6b | 43.3x | 41.1x | 5.3x |
| Thu, 27 Jan 2022 | ر.س106.9b | ر.س20.2b | ر.س2.6b | 45.2x | 41.7x | 5.3x |
Price to Earnings Ratio
41.7x
Current Industry PE
- Investors are pessimistic on the Saudi Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 40.8x which is lower than its 3-year average PE of 46.9x.
- The industry is trading close to its 3-year average PS ratio of 6.2x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 28% per year over the last three years.
- Revenues for these companies have grown 24% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Saudi Arabian Healthcare sector?
| SA Market | 1.08% | |
| Healthcare | -0.54% | |
| Medical Equipment | 0% | 0 |
| Healthtech | 0% | 0 |
| Biotech | 0% | 0 |
| Life Sciences | 0% | 0 |
| Pharma | -0.32% | |
| Healthcare Services | -0.57% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 45.7x.
- Analysts expect its future annual earnings growth (14.6%) to be largely in line with prior year's earnings growth.
- Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 48.8x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 16% over the next 5 years.
- However this is lower than its past earnings growth rate of 60% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 15% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4002 Mouwasat Medical Services | ر.س92.80 | 6.9% +ر.س1.2b | -22.8% | PE28.2x | |
| 2230 Saudi Chemical Holding | ر.س10.02 | 5.7% +ر.س455.3m | 111.8% | PE25.9x | |
| 4015 Jamjoom Pharmaceuticals Factory | ر.س162.40 | 4.0% +ر.س434.0m | 20.1% | PE32.5x | |
| 4018 Almoosa Health | ر.س138.00 | 5.5% +ر.س319.0m | n/a | PE100.9x | |
| 4009 Middle East Healthcare | ر.س75.20 | 3.3% +ر.س220.9m | -21.3% | PE32.7x |
